Finance

Lists
Why is 4TZ down 7.72%?
Dive Deeper
4TZ:FRA
ORIC Pharmaceuticals Inc
€7.89
-7.72%
(-0.66) 1D
Nov 5, 3:59:02 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4TZ...
Open
€8.18
High
€8.18
Low
€7.89
Mkt. cap
906.96M
Avg. vol.
1.00
Volume
0.00
52-wk high
€12.32
52-wk low
€6.10
No. of employees
111
Open
€8.18
High
€8.18
Low
€7.89
Mkt. cap
906.96M
Avg. vol.
1.00
Volume
0.00
52-wk high
€12.32
52-wk low
€6.10
No. of employees
111
News stories
From web sources and news partners
About ORIC Pharmaceuticals Inc
CEO-
Employees111
Founded2014
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Industry-
Websiteoricpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.77M
25.86M
31.44M
36.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.90M
8.70M
8.18M
9.00M
Operating expense
36.67M
34.55M
39.62M
45.30M
Total operating expenses
36.67M
34.55M
39.62M
45.30M
Operating income
-36.67M
-34.55M
-39.62M
-45.30M
Other non operating income
-
-
-
-
EBT including unusual items
-32.59M
-30.50M
-35.77M
-41.49M
EBT excluding unusual items
-32.59M
-30.50M
-35.77M
-41.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32.59M
-30.50M
-35.77M
-41.49M
Net profit margin
-
-
-
-
Earnings per share
-0.33
-0.30
-0.34
-0.38
Interest and investment income
4.08M
4.05M
3.85M
3.80M
Interest expense
-
-
-
-
Net interest expenses
4.08M
4.05M
3.85M
3.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.38M
-34.23M
-39.35M
-45.03M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps